Home > Insider Trading > Brickell Biotech Inc. > Profile

Brickell Biotech Inc. (BBI)

Sector: Biological Products, (No Disgnostic Substances)

Related Insiders

L Reginald Hardy, Chairman Of The Board, 2022-05-17
B Vijay Samant, Director, 2022-05-17
A Gary Lyons, Director, 2022-05-17

L Reginald Hardy, Chairman Of The Board, 2022-05-17
B Vijay Samant, Director, 2022-05-17
A Gary Lyons, Director, 2022-05-17
T Dennison Veru, Director, 2022-05-17
R. David Mcavoy, General Counsel And Cco, 2022-05-09
Jose Breton, Chief Accounting Officer, 2022-05-09
Deepak Chadha, Chief Research & Dev. Officer, 2022-05-09
Ii N Albert Marchio, Chief Financial Officer, 2022-05-09
E. Monica Luchi, Chief Medical Officer, 2022-05-09
D Andrew Sklawer, Coo And Secretary, 2022-05-09
Busard Robert Brown, Chief Executive Officer, 2022-05-09
Michael R Carruthers, Chief Financial Officer, 2020-03-18
Scott Adam Levy, Chief Business Officer, 2020-03-18
B George Abercrombie, Chief Executive Officer, 2020-02-19
Sanjeev Ahuja, Chief Medical Officer, 2019-11-05
William Ju, , 2019-09-10
Steven Boyd, Large Shareholder, 2019-01-14
Ltd. Fund Master Capital Armistice, Large Shareholder, 2019-01-14
Armistice Capital, Llc, Large Shareholder, 2019-01-14
C Robert Merton, Director, 2018-05-24
M Richard Beleson, Director, 2018-05-24
J George Morrow, Director, 2018-05-24
Gordon R Douglas, Director, 2018-05-24
E Thomas Shenk, Director, 2018-05-24
Mammen Mammen, Sr Vp, Clinical Development, 2018-01-10
Alan Anthony Ramos, Vp, Chief Financial Officer, 2018-01-10
Russell Lawrence Smith, Sr Vp, Research, 2018-01-10
Anges Mg, Inc., , 2016-08-10
Igor Bilinsky, Sr Vp, Corporate Development, 2015-07-15
A Stephen Sherwin, Director, 2015-05-26
R James Singer, Large Shareholder, 2013-09-12
Phd P Alain Rolland, Exec Vp, Product Development, 2013-08-23
Marie Jill Broadfoot, Sr Vice President, Cfo, Sec, 2013-04-03
H Robert Campbell, Director, 2012-11-28
M David Greenhouse & W Austin Marxe, Large Shareholder, 2009-07-28
Private Sciences Life Temasek Ltd Pte Investments V-Sciences, Large Shareholder, 2009-05-22

Show All Insiders (36)

Hedge Fund Popularity

Display

Display Share Price

Display Large Version

Hedge Fund Holdings

Filing Period:

Last updated on November 14, 2019, 9:00 pm based on SEC 13F filings Last update: November 14, 2019, 9:00 pm

No.	Hedge Fund	Value (x$1000)	% Port
1.	Renaissance Technologies Jim Simons	$0	0%
2.	Citadel Investment Group Ken Griffin	$0	0%
3.	Citadel Investment GroupCALL Ken Griffin	$0	0%
4.	Sio Capital Michael Castor	$0	0%
5.	Biotechnology Value Fund / BVF Inc Mark Lampert	$0	0%

Insider Trading: Purchases See All

Insider	Price	Amount	Relationship	Remaining Holdings	Date	Form 4
Hardy	$0.67	100,000	Officer, Director	448,411	2021-07-26	Filing
Hardy	$0.66	100,000	Officer, Director	348,411	2021-07-23	Filing
Mcavoy	$0.67	18,124	Officer	128,879	2021-07-23	Filing
Sklawer	$0.80	15,375	Officer	124,625	2021-05-17	Filing
Mcavoy	$0.80	7,980	Officer	13,980	2021-05-17	Filing

Insider Trading: Sales See All

Insider	Price	Amount	Relationship	Remaining Holdings	Date	Form 4
Armistice	$0.00	0	Large Shareholder	2,170,000	2019-01-10	Filing
Armistice	$0.00	0	Large Shareholder	2,170,000	2019-01-10	Filing
Armistice	$0.88	2,190,500	Large Shareholder	2,170,000	2019-01-10	Filing
Ramos	$2.17	4,250	Officer	9,674	2017-03-27	Filing
Smith	$2.31	875	Officer	17,696	2017-03-15	Filing